MX2024011264A - Un proceso para la sintesis de acido (r)-2-((terc-butoxicarbonil)a mino)-3- (dietoxifosforil)propanoico o de derivados fosfonato del mismo. - Google Patents

Un proceso para la sintesis de acido (r)-2-((terc-butoxicarbonil)a mino)-3- (dietoxifosforil)propanoico o de derivados fosfonato del mismo.

Info

Publication number
MX2024011264A
MX2024011264A MX2024011264A MX2024011264A MX2024011264A MX 2024011264 A MX2024011264 A MX 2024011264A MX 2024011264 A MX2024011264 A MX 2024011264A MX 2024011264 A MX2024011264 A MX 2024011264A MX 2024011264 A MX2024011264 A MX 2024011264A
Authority
MX
Mexico
Prior art keywords
amino
diethoxyphosphoryl
butoxycarbonyl
synthesis
compound
Prior art date
Application number
MX2024011264A
Other languages
English (en)
Spanish (es)
Inventor
Gareth Brown
Stefan Abele
Peter Mcintyre
Stefan MIX
Original Assignee
Viatris Asia Pacific Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Asia Pacific Pte Ltd filed Critical Viatris Asia Pacific Pte Ltd
Publication of MX2024011264A publication Critical patent/MX2024011264A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2024011264A 2022-03-14 2023-03-10 Un proceso para la sintesis de acido (r)-2-((terc-butoxicarbonil)a mino)-3- (dietoxifosforil)propanoico o de derivados fosfonato del mismo. MX2024011264A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2022056471 2022-03-14
PCT/EP2023/056138 WO2023174810A1 (en) 2022-03-14 2023-03-10 A process for the synthesis of ( r)-2-(( tert-butoxycarbonyl)amino)-3-(diethoxyphosphoryl)propanoic acid or of phosphonate derivatives thereof

Publications (1)

Publication Number Publication Date
MX2024011264A true MX2024011264A (es) 2024-09-23

Family

ID=85571281

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024011264A MX2024011264A (es) 2022-03-14 2023-03-10 Un proceso para la sintesis de acido (r)-2-((terc-butoxicarbonil)a mino)-3- (dietoxifosforil)propanoico o de derivados fosfonato del mismo.

Country Status (10)

Country Link
US (1) US20250197904A1 (cg-RX-API-DMAC7.html)
EP (1) EP4493565A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025509711A (cg-RX-API-DMAC7.html)
KR (1) KR20240172742A (cg-RX-API-DMAC7.html)
CN (1) CN118871446A (cg-RX-API-DMAC7.html)
CA (1) CA3245480A1 (cg-RX-API-DMAC7.html)
IL (1) IL315504A (cg-RX-API-DMAC7.html)
MX (1) MX2024011264A (cg-RX-API-DMAC7.html)
TW (1) TW202345856A (cg-RX-API-DMAC7.html)
WO (1) WO2023174810A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2483072C2 (ru) 2007-11-29 2013-05-27 Актелион Фармасьютиклз Лтд Производные фосфоновой кислоты и их применение в качестве антагонистов рецептора p2y12
SG11201908128YA (en) 2017-03-15 2019-10-30 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a p2y12 receptor antagonist

Also Published As

Publication number Publication date
IL315504A (en) 2024-11-01
KR20240172742A (ko) 2024-12-10
EP4493565A1 (en) 2025-01-22
US20250197904A1 (en) 2025-06-19
CA3245480A1 (en) 2023-09-21
CN118871446A (zh) 2024-10-29
WO2023174810A1 (en) 2023-09-21
JP2025509711A (ja) 2025-04-11
TW202345856A (zh) 2023-12-01

Similar Documents

Publication Publication Date Title
EP0073143B1 (en) Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides
US20230265070A1 (en) Novel usp7 inhibitors for treating multiple myeloma
US20230234924A1 (en) Yap1 inhibitors that target the interaction of yap1 with oct4
MXPA02007819A (es) Sales cristalinas del acido 7-[4-(4-fluorofenil)-6-isopropil-2-[metil(metilsulfonil) amino)pirimidin-5-il)-(3r, 5s)-3, 5-dihidroxihept-6-enoico.
JPH09208545A (ja) アルコールまたはアルデヒド誘導体およびその用途
JPS61152650A (ja) コラゲナーゼ阻害剤
CZ129694A3 (en) Novel peptide derivatives
HU228985B1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
JPWO2008099874A1 (ja) ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法
AU2009225747A1 (en) S1P3 receptor inhibitors for treating inflammation
HUP0102732A2 (hu) Szubsztituált amidok, alkalmazásuk gyógyszerkészítmények előállítására és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
MX2025004961A (es) Derivados de triazinona como inhibidores de inflamasoma de proteina 3 que contiene dominios de pirina (nlrp3)
AU657018B2 (en) Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use
ZA200007757B (en) New heterocyclically substituted amides, their production and their use.
MX2025010256A (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno
MX2024013978A (es) Derivados de oxoindolinil amida para inhibir proteina que contiene dominios nod, lrr y pirina 3 (nlrp3) y usos de los mismos
AU2021334987B2 (en) Inhibitors of Pseudomonas aeruginosa virulence factor LasB
CA2121313A1 (en) Heterocyclic iminobismethylenebisphosphonic acid derivatives
AU2010305397B2 (en) Method for the synthesis of 2-thiohistidine and the like
JP2023529047A (ja) 組織損傷の治療に使用するための作用剤
WO2023044315A3 (en) Kca3.1 inhibitors for podocyte protection
ZA200507240B (en) MEthod for the production of bicyclic aromatic amino acids and intermediate products thereof
MX2024000653A (es) Un proceso para la sintesis de ester de butilo de acido 4-((r)-2-{[6-((s)-3-metoxi-pirrolidin-1-il)-2-fenil-pirimidin-4-c arbonil]-amino}-3-fosfono-propionil)-piperazin-1-carboxilico.
DE69905397T2 (de) Selektive inhibitoren des mmp-12
TW202617749A (zh) 一種psd-95多肽抑制劑的可藥用鹽及其製備方法